About: http://data.cimple.eu/news-article/a552852b0091fa3a829c2e77b023080d487c2627002fb05b28f1e3ad

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/a552852b0091fa3a829c2e77b023080d487c2627002fb05b28f1e3ad Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Singapore has approved the use of the anti-viral drug remdesivir to treat seriously ill coronavirus patients, authorities said Wednesday, becoming the latest country to do so. The US authorised the emergency use of remdesivir in hospitals at the start of May, followed by Japan and South Korea, while Europe has been considering following suit. It has been granted conditional approval in Singapore for treatment of some adult virus patients, such as those who require intensive breathing support, the country's health products regulator said. The regulator, the Health Sciences Authority, said it had "expedited the review of remdesivir given the urgent public health need during the COVID-19 pandemic". As a condition for the approval, the authority requires US-based Gilead Sciences, which developed the drug, to collect safety data and monitor its use. Singapore initially kept the virus in check with a strict regime of testing and contact tracing, only for serious outbreaks to emerge later in dormitories housing low-paid foreign workers. The city-state now has the highest recorded number of infections in Southeast Asia with nearly 39,000 cases, mostly among foreign workers. The death toll stands at 25. mba/sr/mtp
schema:headline	Singapore approves anti-viral drug for COVID-19 patients
schema:mentions	Master of Business Administration Southeast Asia Contact tracing Antiviral drug Remdesivir Public health Ebola virus disease South Korea Singapore Europe Japan Pandemic Severe acute respiratory syndrome coronavirus 2 Health Sciences Authority Gilead Sciences
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-06-10 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	83 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software